Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Pacing Clin Electrophysiol. 2019 Oct 18;42(11):1440–1447. doi: 10.1111/pace.13805

Table 2.

Patient Characteristics by AF Recurrence

Characteristic Overall (N=230) AF Free (N=154) AF Recurrence (N=76) p value
Age (years) 66.0 (59.0, 74.0) 66.0 (59.0, 74.0) 67.0 (57.0, 73.0) 0.726
Female 70 (30.4%) 49 (31.8%) 21 (27.6%) 0.516
BMI (kg/m2) 31.4(27.7, 37.1) 31.0 (27.7, 36.7) 32.2 (28.4, 37.4) 0.331
AF Type
Paroxysmal 80 (34.8%) 54 (35.1%) 26 (34.2%) 0.484
Persistent 48 (20.9%) 36 (23.4%) 12 (15.8%)
Long-standing 54 (23.5%) 35 (22.7%) 19 (25.0%)
Persistent
Baseline NYHA Class
I 67 (33.3%) 43 (32.3%) 24 (35.3%) 0.671
II 103 (51.2%) 71 (53.4%) 32 (47.1%)
III/IV 31 (15.4%) 19 (14.3%) 12 (17.6%)
eGFR (mL/min) 92.1 (69.8, 122.2) 89.4 (68.9, 115.3) 94.6 (72.0, 137.4) 0.278
Left atrial diameter (cm) 4.6 (0.8) 4.5 (0.8) 4.7 (0.8) 0.190
LVEF <50% 129 (56.1%) 86 (55.8%) 43 (56.6%) 0.916
Coronary artery disease 103 (45.0%) 74 (48.1%) 29 (38.7%) 0.180
Hypertension 192 (83.5%) 133 (86.4%) 59 (77.6%) 0.094
Diabetes mellitus 58 (25.4%) 38 (25.0%) 20 (26.3%) 0.830
COPD 26 (11.4%) 17 (11.2%) 9 (11.8%) 0.883
OSA 0.934
None 133 (58.1%) 90 (58.8%) 43 (56.6%)
Yes, untreated 28 (12.2%) 18 (11.8%) 10 (13.2%)
Yes, treated 68 (29.7%) 45 (29.4%) 23 (30.3%)
Stroke/TIA 34 (15.0%) 25 (16.6%) 9 (12.0%) 0.367
Mitral Regurgitation 32 (13.9%) 21 (13.6%) 11 (14.5%) 0.863
AAD failed 0.545
None 81 (35.2%) 57 (37.0%) 24 (31.6%)
1–2 148 (64.3%) 96 (62.3%) 52 (68.4%)
>2 1 (0.4%) 1 (0.6%) 0 (0.0%)

Note: Categorical data presented as count (percentage) and continuous data as mean (standard deviation) or median (Q1, Q3). AAD = anti-arrhythmic drug. AF = atrial fibrillation. BMI = body mass index (kg/m2). COPD = chronic obstructive pulmonary disease. NYHA = New York Heart Association Functional Classification. LVEF = left ventriuclar ejection fraction. OSA = obstructive sleep apnea. TIA = transient ischemic attack.